XDSI introduces EPA Approved Method 4435 to Chile

Durham, NC - May 12, 2009 - "XDSI introduces EPA Approved Method 4435 to Chile. Its bioassay will be used commercially to screen waste material from mines, paper mills and other industrial areas for screening of materials for incineration. The country of Chile is taking great steps to avoid further contamination from Dioxins and PCBs in its environment. In addition, Method 4435 will be used to screen mineral supplements, other feed additives, and food for export to the European Union. Chile will meet all EU standards for the acceptable levels of dioxins in chicken, pork, beef and fish. XDSI has created a Chilean company in partnership with University Adolfo Ibanez/Venture Lab and Gene Xpress. This new company will be called XDSI-SPA. Its partner, Gene Xpress will promote for not only the country of Chile, but will promote XDS-CALUX and Lumi-Cell throughout the rest of Latin America. Links to its partners are www.genex.cl and www.venturelab.biz . Venture L@b/UAI will provide the facilities and expertise for research into other bioassays for XDSI. University Adolfo Ibanez is the best business school in Chile and has more patents per square foot of research facility than any other research facility in Latin America."

Full Press Release (PDF)

Poland Selects Xenobiotic Detection Systems for Biotechnology License

Durham, NC – January 18, 2005 – Xenobiotic Detection Systems’ (XDS) patented XDS CALUX^® technology has been selected by the Government of Poland as a screening tool for detection of chemical contamination of the food supply. This is the first licensing of XDS dioxin detection technology to Poland and the third license in the European Union for the North Carolina company.

Full Press Release (PDF)

Hiyoshi Corporation Appointed XDS’s Sole Agent in Japan.

Durham, NC and Shiga, Japan – February 4, 2003 – Xenobiotic Detection Systems, Inc. (XDS) announced that the Hiyoshi Corporation of Shiga, Japan, has been appointed the company’s sole agent for Japan. Hiyoshi will now be responsible for all aspects of XDS’s patented (CALUX^®) Chemical Activated Luciferase Gene Expression bioassay within Japan. The corporation will market and license the dioxin detection technology to Japanese laboratories and industries. In addition, Hiyoshi will provide all of the training to laboratory staff and will assist new licensees in establishing and equipping their laboratories.

FDA Selects Xenobiotic Detection Systems’ Bio-Assay for Dioxin Research

Durham, NC – October 25, 2001 – Xenobiotic Detection Systems’ (XDS) patented CALUX^® technology has been selected by the Food and Drug Administration (FDA) for investigation as a possible screening tool for chemical contamination of the food supply. The FDA Center for Veterinary Medicine (CVM) and the FDA Office of Regulatory Affairs (ORA), Arkansas Regional Laboratory (ARL) have signed a licensing agreement to use the CALUX^® bioassay for investigation as a new technology in the detection of dioxin-like compounds.

Full Press Release (PDF)

XDS INTRODUCES ITS NEW TECHNIQUE IN BELGIUM TO TACKLE FOOD CONTAMINATION

Durham, NC – September 20, 2000 – Xenobiotic Detection Systems has been selected by the Belgium government to help protect the country’s residents and food supply from chemical contamination. Belgium has licensed Xenobiotic’s CALUX^® technology for the detection of Dioxin-like compounds, which are the by-products of several industrial processes including the incineration of waste that contains chlorine. These dioxin-like compounds can be a hazard to the food supply because after they are produced they can be bio-concentrated and end up in processed animal feed, tissue and food samples.

Full Press Release (PDF)